查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2014547

跳蚤和蜱虫防治产品市场：按产品类型、目标动物和销售管道分類的全球市场预测，2026-2032年

Flea & Tick Product Market by Product Type, Animal Type, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，跳蚤和蜱虫防治产品市场价值将达到 18.9 亿美元，到 2026 年将成长到 20.2 亿美元，到 2032 年将达到 30.2 亿美元，复合年增长率为 6.93%。

主要市场统计数据
基准年 2025 18.9亿美元
预计年份：2026年 20.2亿美元
预测年份 2032 30.2亿美元
复合年增长率 (%) 6.93%

本文全面概述了宠物饲养模式的变化、监管重点和消费者期望如何重塑该类别的产品和销售管道重点。

受宠物饲养模式的改变、消费者对安全性和便利性日益增长的期望以及监管力度加大的影响，跳蚤和蜱虫防治产品的市场格局正进入一个战略关注度更高的阶段。产品开发、分销和兽医服务领域的相关人员正在重新评估产品的定位，力求在有效性、易用性和负责任的管理之间取得平衡。随着宠物与家庭的融合程度越来越高，家庭结构也朝着更「人性化」的方向发展，市场需求的驱动因素正在重新定义何为「可接受的」、「优质的」或「必要的」干预措施。

简要分析推动产品开发和分销管道创新和新兴竞争动态的技术、行为和监管变化。

跳蚤和蜱虫防治产品领域近期发生的变革性变化，反映了由技术进步、宠物饲主行为变化以及法规结构强化所驱动的竞争优势的重新定义。药物科学的进步使得更易偏好的口服药物和药效更持久的外用製剂得以研发，从而影响了消费者的偏好和用药依从性。同时，数位化资讯管道和远距远端医疗互动提高了消费者的认知度，使他们成为更明智的消费者，要求产品提供基于实证医学的疗效声明和透明的安全资讯。

对近期关税调整如何促进供应链多元化、采购韧性和协调定价策略的营运和商业分析。

美国于2025年实施的新关税措施进一步增加了跳蚤和蜱虫防治产品生态系统中企业的供应链和采购复杂性。关税调整迫使企业重新评估筹资策略，促使它们更加重视供应商多元化和近岸外包。这种调整影响了前置作业时间、库存策略和采购成本基准值，需要商业规划和供应链营运之间更紧密的协调。

从详细的细分观点解释产品剂型、动物物种特定考虑因素和销售管道选择如何共同塑造产品渗透趋势和策略权衡。

了解市场区隔动态对于跳蚤和蜱虫防治产品系列的开发和市场进入策略至关重要。根据产品类型，市场可细分为项圈、口服药物、洗髮精/浸泡液、滴剂和喷雾剂，其中口服药物可进一步细分为咀嚼片和片剂。每种剂型都具有独特的特性，这些特性与饲主的便利性、剂量准确性和安全性密切相关。例如，项圈是一种被动式、使用频率低的干预措施，适合希望尽量减少麻烦的饲主。滴剂虽然需要局部涂抹，但通常因其起效迅速和使用方便而受到青睐。口服药物，无论是咀嚼锭或锭剂，如果偏好和给药方式得到最佳化，通常有助于提高遵守用药性。

区域分析解释了不同的管理体制、消费者行为和分销基础设施如何塑造美洲、欧洲、中东、非洲和亚太地区的区域策略。

区域趋势对全球跳蚤和蜱虫防治产业的监管环境、消费者偏好和分销基础设施有显着影响。在美洲，消费者需求模式和兽医分销网络共同创造了一个专家建议与传统零售通路并存的环境，这就要求製造商将临床资讯与零售讯息相协调。在欧洲、中东和非洲，法规结构和文化习俗呈现出多元化的特点，因此，区域安全演示和标籤标准化对于跨境市场准入至关重要。在某些地区，环境管理和残留物问题尤其需要关注。亚太地区的特点是快速的都市化和多元化的零售现代化，这两者共同加速了线上销售的普及，同时也要求企业进行符合当地文化的定位，以适应宠物护理传统和兽医实践。

策略竞争概览，展示了成熟品牌、敏捷创新者和通路伙伴关係如何定义竞争格局和产品差异化策略。

跳蚤和蜱虫防治产品市场的竞争格局呈现出多元化的态势，既有老牌企业，也有利用配方技术进步的参与企业，还有专注于特定给药系统的专业创新者。老牌企业优先考虑可靠的临床数据和广泛的分销协议，以维护与兽医专业人士和零售合作伙伴的关係，并持续投资于产品改进和品牌信誉的提升。同时，灵活的製造商和自有品牌开发商正在开发差异化提案，强调更简单的给药方法、良好的安全性或更低的成本，以吸引对价格敏感的消费者。

为经营团队提供切实可行的策略建议，以协调研发、供应链韧性和通路主导的商业化，从而确保可持续的竞争优势。

产业领导企业可以采取实际措施，增强韧性，并在产品、价值链和商业领域加速价值创造。首先，应优先加强研发、监管和商业团队之间的跨职能协作，确保产品创新得到数据和展示策略的支持，从而实现快速推广。这种协作能够减少产品上市的阻力，并打造出能引起临床医师和消费者共鸣的可信赖产品。其次，应实现供应商网路多元化，并探索近岸外包和在地化生产方案，以降低贸易政策波动带来的风险，并缩短关键零件的前置作业时间。

对调查方法进行了清晰严谨的描述，解释瞭如何将一手访谈、第二手资料整合和专家检验结合起来，从而得出可靠且可操作的见解。

本分析的调查方法结合了质性访谈、二手文献整合以及跨领域专家检验，旨在得出平衡且切实可行的结论。一手资料包括对製造和分销机构的产品开发经理、监管专家、供应链经理和销售主管进行的结构化访谈，以获取有关营运限制因素和战略重点的第一手观点。二手资料整合则利用公开的监管公告、临床试验摘要和行业评论，为观察到的行业趋势和监管动态提供背景资讯。

透过整合产品创新、区域特征、监管压力和营运韧性进行分析，为决策者得出连贯的策略结论。

总之，跳蚤和蜱虫防治产品类型正经历着策略重组，其驱动力包括剂型创新、消费者行为更加理性以及监管趋势对更强证据和供应链韧性的要求。产品按剂型（项圈、口服药物、洗髮精/浸液、滴剂、喷雾剂）、物种特异性（猫和狗）以及线上线下分销渠道的不同趋势进行细分，这些因素都带来了关键的商业挑战。同时，美洲、欧洲、中东和非洲以及亚太地区的区域差异也要求制定在地化的策略，以尊重监管细则和文化偏好。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 跳蚤和蜱虫防治产品市场：依产品类型划分

  • 衣领
  • 口服
    • 咀嚼片
    • 药片
  • 洗髮精浸泡
  • 完全正确
  • 喷

第九章 跳蚤和蜱虫防治产品市场：依动物类型划分

  • 猫
  • 狗

第十章 跳蚤和蜱虫防治产品市场：按分销管道划分

  • 离线
  • 在线的

第十一章 跳蚤和蜱虫防治产品市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章 跳蚤和蜱虫防治产品市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章 跳蚤和蜱虫防治产品市场：按国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章：美国跳蚤和蜱虫防治产品市场

第十五章：中国跳蚤和蜱虫防治产品市场

第十六章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Advanced PetCare of Northern Nevada, Inc.
  • Beaphar BV
  • Boehringer Ingelheim International GmbH
  • Central Garden & Pet Company
  • Ceva Sante Animale SA
  • Dechra Pharmaceuticals PLC
  • Ecto Development Corporation
  • Elanco Animal Health Incorporated
  • Eli Lilly and Company
  • Godrej Consumer Products Limited
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • Merck & Co., Inc.
  • Merial
  • Norbrook Laboratories Limited
  • PetIQ, Inc.
  • Radio Systems Corporation
  • Sergeant's Pet Care Products, Inc.
  • Sogeval SA
  • Spectrum Brands Holdings, Inc.
  • Sumitomo Chemical Co., Ltd.
  • The Hartz Mountain Corporation
  • Vetoquinol SA
  • Virbac SA
  • Wellmark International, Inc.
  • Zoetis Inc.
Product Code: MRR-4348D129FB5F

The Flea & Tick Product Market was valued at USD 1.89 billion in 2025 and is projected to grow to USD 2.02 billion in 2026, with a CAGR of 6.93%, reaching USD 3.02 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.89 billion
Estimated Year [2026] USD 2.02 billion
Forecast Year [2032] USD 3.02 billion
CAGR (%) 6.93%

An integrative introduction describing how shifting pet ownership patterns, regulatory emphasis, and consumer expectations are reshaping product and channel priorities in the category

The landscape for flea and tick products has entered a phase of heightened strategic attention driven by evolving pet ownership patterns, rising consumer expectations for safety and convenience, and intensifying regulatory scrutiny. Stakeholders across product development, distribution, and veterinary services are reassessing how to position offerings that need to balance efficacy, ease of use, and responsible stewardship. As pets become integrated into more households and family dynamics shift toward humanization, demand drivers are recalibrating what constitutes an acceptable, premium, or essential intervention.

Manufacturers are responding by reformulating delivery mechanisms and emphasizing differentiated claims that align with contemporary pet parent priorities, such as long-lasting protection, palatable oral formats, and topical options that minimize stress during administration. In parallel, retailers and veterinary networks are adapting merchandising and educational strategies to address buyer literacy about product trade-offs and behavioral adherence. These converging trends are fostering an environment where product innovation, clear communication, and robust safety data are core determinants of commercial success.

Transitioning from traditional category playbooks, companies now prioritize integrated go-to-market strategies that combine clinical credibility with consumer-centric convenience. This shift demands a deeper understanding of how product attributes, animal type considerations, and channel experiences intersect to shape purchasing decisions and long-term loyalty.

A concise exploration of the technological, behavioral, and regulatory shifts catalyzing innovation and new competitive dynamics across product development and distribution channels

Recent transformative shifts in the flea and tick product environment reflect a confluence of technological advances, behavioral changes among pet owners, and tightened regulatory frameworks that together redefine competitive advantage. Advances in formulation science have enabled the development of oral options with improved palatability and topical agents with longer residual activity, which in turn influence consumer preference hierarchies and adherence patterns. Concurrently, digital information channels and telehealth interactions have elevated consumer awareness, creating more informed purchasers who demand evidence-based claims and transparent safety profiles.

Moreover, the retail landscape has evolved as omnichannel expectations increase; consumers expect seamless discovery, access to professional guidance, and convenient replenishment regardless of whether they shop through brick-and-mortar clinics, mass-market retailers, or online platforms. This behavioral shift pressures manufacturers to deliver clear, consistent messaging across disparate touchpoints. At the same time, regulatory authorities have intensified oversight on active ingredient approvals, labeling precision, and claims substantiation, prompting firms to invest in stronger clinical and safety data packages.

Taken together, these shifts are pushing industry players to blend scientific rigor with consumer-centric design and multichannel execution, thereby privileging organizations that can pivot quickly while maintaining trust and compliance.

An operational and commercial analysis of how recent tariff adjustments have compelled supply chain diversification, procurement resilience, and collaborative pricing strategies

The introduction of new tariff measures within the United States in 2025 has introduced a layer of supply chain and procurement complexity for companies active in the flea and tick product ecosystem. Tariff adjustments have prompted firms to re-evaluate sourcing strategies for active pharmaceutical ingredients and packaging components, with greater attention on supplier diversification and nearshoring alternatives. This recalibration has implications for lead times, inventory policies, and procurement cost baselines, requiring tighter coordination between commercial planning and supply chain operations.

As a result, manufacturers that had relied on single-source international suppliers have accelerated efforts to qualify secondary suppliers and to secure contingency inventory where feasible. Firms also increased engagement with logistics providers to mitigate shipment delays and to optimize routing that minimizes exposure to incremental duties. In parallel, procurement teams implemented more granular cost-to-serve analyses to understand how tariff-induced cost changes influence pricing flexibility and margin trade-offs.

Importantly, the tariff environment is encouraging strategic dialogues between manufacturers and distribution partners about cost-sharing mechanisms, rebate structures, and promotional commitments to preserve retail price competitiveness. These conversations frequently lead to collaborative scenarios where commercial teams prioritize product bundles, subscription models, or promotional cadence adjustments to sustain volume while absorbing part of the cost impact. In sum, tariff-driven pressures are reshaping operational resilience and commercial negotiations, reinforcing the importance of integrated cross-functional planning.

A nuanced segmentation perspective explaining how product delivery formats, animal-specific considerations, and channel selection converge to shape adoption dynamics and strategic trade-offs

Understanding segmentation dynamics is critical to shaping product portfolios and go-to-market strategies within the flea and tick category. Based on product type, the market is studied across Collar, Oral, Shampoo & Dip, Spot-On, and Spray, with Oral further differentiated into Chewable and Tablet; each delivery format carries distinct attributes related to owner convenience, dosing accuracy, and perceived safety. For instance, collars provide passive, low-frequency intervention suitable for owners seeking minimal handling, whereas spot-on formulations require topical application and are often chosen for perceived immediacy and ease of use. Oral formats, whether chewable or tablet, frequently benefit from adherence advantages when palatability and administration are optimized.

Based on animal type, the market is studied across Cat and Dog, and species-specific physiology, tolerance profiles, and behavioral characteristics influence product suitability and label design. Cats, for example, necessitate formulations with stricter safety margins and careful consideration of grooming behavior, while dogs offer broader formulation options that must account for size and weight variability. Based on distribution channel, the market is studied across Offline and Online, and channel choice strongly shapes purchasing behavior, educational touchpoints, and repeat-buy mechanisms. Offline channels, including veterinary clinics and specialty retailers, often serve as trusted advisors that influence adoption through professional recommendation, whereas online channels expand access and enable subscription-based replenishment models that reward stickiness.

Consequently, segmentation insights inform targeted messaging, packaging decisions, and clinical evidence investments required to win in each product-animal-channel intersection.

A regional analysis describing how divergent regulatory regimes, consumer behaviors, and distribution infrastructures shape tailored strategies in the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics exert a powerful influence on regulatory approaches, consumer preferences, and distribution infrastructures across the global flea and tick landscape. In the Americas, consumer demand patterns and veterinary distribution networks create an environment where professional endorsement and familiar retail channels coexist, prompting manufacturers to align clinical communication with retail-friendly messaging. Europe, Middle East & Africa present a mosaic of regulatory frameworks and cultural practices that necessitate localized safety substantiation and label harmonization to achieve cross-border access, with particular attention to environmental stewardship and residue considerations in certain jurisdictions. Asia-Pacific is characterized by rapid urbanization and diverse retail modernization trajectories, which together accelerate online adoption while also requiring culturally relevant positioning to address pet care traditions and veterinary practice norms.

Across these regions, differences in reimbursement models, veterinary density, and consumer willingness to pay influence how products are marketed and supported. Manufacturers must therefore calibrate their regional strategies to balance centralized global platforms with local market adaptations, ensuring that product claims, packaging language, and educational assets resonate with local stakeholders. Additionally, supply chain configuration and regulatory registration timelines vary by region, reinforcing the need for phased market entry plans that align manufacturing capacity with incremental market access milestones.

In effect, regional insights guide choices around portfolio prioritization, evidence generation, and channel investment to maximize relevance and operational feasibility in distinct geographies.

A strategic competitive overview illustrating how established brands, agile innovators, and channel partnerships are defining the competitive contours and product differentiation strategies

Competitive dynamics within the flea and tick product landscape reflect a blend of legacy brand strength, new entrants leveraging formulation advances, and specialist innovators focused on niche delivery systems. Established companies continue to invest in incremental product improvements and brand trust, emphasizing robust clinical data and broad distribution agreements to maintain relationships with veterinary professionals and retail partners. At the same time, agile manufacturers and private-label players introduce differentiated propositions that emphasize simpler administration, favorable safety profiles, or lower-cost alternatives that appeal to cost-sensitive segments.

Strategically, companies are differentiating along multiple vectors: formulation innovation, consumer convenience, evidence-backed claims, and omnichannel presence. Partnerships and strategic alliances between manufacturers and distribution platforms are increasingly common, enabling faster market access and co-marketing opportunities. In addition, several companies are deploying lifecycle management approaches to extend product relevance through line extensions or repackaging that addresses specific animal type needs or channel preferences.

As competition intensifies, leaders combine rigorous clinical programs with targeted marketing and channel strategies, while emerging players focus on speed-to-market and experimental go-to-market models to capture niche demand. Ultimately, success favors organizations that can integrate scientific credibility with pragmatic commercialization capabilities.

Actionable strategic recommendations for executive teams to align R&D, supply chain resilience, and channel-led commercialization for sustained competitive advantage

Industry leaders can take concrete steps to strengthen resilience and accelerate value capture across product, supply chain, and commercial domains. First, prioritize cross-functional integration between R&D, regulatory, and commercial teams to ensure that product innovations are supported by the data and labeling strategies required for rapid adoption. This alignment reduces time-to-adoption friction and supports credible claims that resonate with both clinicians and consumers. Second, diversify supplier networks and evaluate nearshoring or regional manufacturing options to mitigate exposure to trade policy volatility and to shorten lead times for critical components.

Third, refine channel strategies by tailoring messaging and packaging to the distinctive needs of clinic-based veterinary channels and online retail ecosystems, thereby enhancing conversion and repeat purchase rates. Fourth, invest in post-market surveillance and safety communication systems to build trust and enable rapid response to any adverse events or regulatory inquiries. Fifth, pursue targeted partnerships with telehealth providers, subscription platforms, and retailers to expand access while preserving professional oversight.

Finally, adopt a data-driven commercial approach that links segmentation insights to customer lifetime value metrics, enabling prioritized investment in the product-animal-channel combinations that promise the most durable returns. Together, these actions create an adaptable operating model that balances growth with compliance and customer trust.

A clear and rigorous methodological explanation describing how primary interviews, secondary synthesis, and expert validation were combined to produce robust actionable insights

The research methodology underpinning this analysis combines primary qualitative interviews, secondary literature synthesis, and cross-functional expert validation to ensure balanced, actionable conclusions. Primary inputs include structured interviews with product development leaders, regulatory specialists, supply chain managers, and commercial executives across manufacturer and distributor organizations, capturing firsthand perspectives on operational constraints and strategic priorities. Secondary synthesis draws on publicly available regulatory notices, clinical study summaries, and trade commentary to contextualize observed industry behaviors and regulatory trends.

Data triangulation is achieved by cross-referencing interview insights with documented regulatory changes and observable commercial actions such as distribution agreements and product registrations. The analysis also employs scenario-based stress testing to evaluate how policy shifts and supply chain disruptions could influence operational choices without projecting specific market sizes. Findings were iteratively reviewed by subject matter experts to ensure practical relevance and to validate the plausibility of strategic implications.

Transparency of approach is maintained through explicit documentation of data sources, interviewee roles, and analytical assumptions, enabling clients to understand the provenance of conclusions and to adapt the methodology for customized deep dives where necessary.

A synthesis that ties together product innovation, regional nuances, regulatory pressures, and operational resilience into a coherent strategic conclusion for decision-makers

In conclusion, the flea and tick product category is navigating a period of strategic realignment driven by innovation in delivery formats, more informed consumer behavior, and regulatory dynamics that demand stronger evidence and supply chain resilience. Product segmentation across delivery types such as Collar, Oral, Shampoo & Dip, Spot-On, and Spray, animal-specific considerations for Cat and Dog, and the divergent behaviors of Offline and Online distribution channels collectively shape commercial imperatives. Simultaneously, regional variations across the Americas, Europe, Middle East & Africa, and Asia-Pacific necessitate localized strategies that respect regulatory nuances and cultural preferences.

Organizations that succeed will be those that integrate scientific rigor with consumer-centric design, diversify sourcing to manage policy-driven cost and timing shocks, and deploy channel-specific engagement models that reinforce professional trust while leveraging digital convenience. Collaborative commercial mechanisms with trading partners and investments in post-market safety communication will further differentiate leaders. Ultimately, a balanced approach that aligns product innovation with operational resilience and clear, targeted communication will enable companies to navigate current headwinds and capitalize on evolving opportunities in the category.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Flea & Tick Product Market, by Product Type

  • 8.1. Collar
  • 8.2. Oral
    • 8.2.1. Chewable
    • 8.2.2. Tablet
  • 8.3. Shampoo & Dip
  • 8.4. Spot-On
  • 8.5. Spray

9. Flea & Tick Product Market, by Animal Type

  • 9.1. Cat
  • 9.2. Dog

10. Flea & Tick Product Market, by Distribution Channel

  • 10.1. Offline
  • 10.2. Online

11. Flea & Tick Product Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Flea & Tick Product Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Flea & Tick Product Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Flea & Tick Product Market

15. China Flea & Tick Product Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Advanced PetCare of Northern Nevada, Inc.
  • 16.6. Beaphar B.V.
  • 16.7. Boehringer Ingelheim International GmbH
  • 16.8. Central Garden & Pet Company
  • 16.9. Ceva Sante Animale S.A.
  • 16.10. Dechra Pharmaceuticals PLC
  • 16.11. Ecto Development Corporation
  • 16.12. Elanco Animal Health Incorporated
  • 16.13. Eli Lilly and Company
  • 16.14. Godrej Consumer Products Limited
  • 16.15. Heska Corporation
  • 16.16. IDEXX Laboratories, Inc.
  • 16.17. Merck & Co., Inc.
  • 16.18. Merial
  • 16.19. Norbrook Laboratories Limited
  • 16.20. PetIQ, Inc.
  • 16.21. Radio Systems Corporation
  • 16.22. Sergeant's Pet Care Products, Inc.
  • 16.23. Sogeval S.A.
  • 16.24. Spectrum Brands Holdings, Inc.
  • 16.25. Sumitomo Chemical Co., Ltd.
  • 16.26. The Hartz Mountain Corporation
  • 16.27. Vetoquinol S.A.
  • 16.28. Virbac S.A.
  • 16.29. Wellmark International, Inc.
  • 16.30. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FLEA & TICK PRODUCT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FLEA & TICK PRODUCT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES FLEA & TICK PRODUCT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA FLEA & TICK PRODUCT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY COLLAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY COLLAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY COLLAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY CHEWABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY CHEWABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY CHEWABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY SHAMPOO & DIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY SHAMPOO & DIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY SHAMPOO & DIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY SPOT-ON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY SPOT-ON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY SPOT-ON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY CAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY CAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY CAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY DOG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY DOG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY DOG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. AMERICAS FLEA & TICK PRODUCT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 41. AMERICAS FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 42. AMERICAS FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 45. NORTH AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. NORTH AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 47. NORTH AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 50. LATIN AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. LATIN AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. LATIN AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. MIDDLE EAST FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. MIDDLE EAST FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. MIDDLE EAST FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 68. MIDDLE EAST FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. MIDDLE EAST FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 70. AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 73. AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. ASEAN FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. ASEAN FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. ASEAN FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 84. ASEAN FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. ASEAN FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. GCC FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GCC FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. GCC FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 89. GCC FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. GCC FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPEAN UNION FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPEAN UNION FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPEAN UNION FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPEAN UNION FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPEAN UNION FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. BRICS FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. BRICS FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. BRICS FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 99. BRICS FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. BRICS FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. G7 FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. G7 FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. G7 FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 104. G7 FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. G7 FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. NATO FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. NATO FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NATO FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 109. NATO FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NATO FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. UNITED STATES FLEA & TICK PRODUCT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. UNITED STATES FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. UNITED STATES FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 115. UNITED STATES FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. UNITED STATES FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. CHINA FLEA & TICK PRODUCT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. CHINA FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. CHINA FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 120. CHINA FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. CHINA FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)